Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Medicamen Biotech Ltd.

BSE: 531146 | NSE: | ISIN: INE646B01010 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Oct 18, 16:00
345.75 -9.15 (-2.58%)
Volume
AVERAGE VOLUME
5-Day
4,274
10-Day
2,715
30-Day
2,618
10,272
  • Prev. Close

    354.90

  • Open Price

    328.05

328.00

Today’s L/H

363.95
306.00

52 Wk L/H

555.95
283.95

L/U Price Band

425.85
  • Bid Price (Qty.)

    339.00 (1)

  • Offer Price (Qty.)

    345.75 (587)

  •  VWAP
    343.80
  • Market Depth (18 Oct 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    42 339.10 344.95 45
    1 339.00 345.00 8
    50 336.05 348.95 1
    5 336.00 349.45 1
    1 335.05 352.75 22
    399 Total Total 764
     Market Depth
    BUY 399.00
    SELL 764.00
    34%
    66%

NSE Live

Dec 27, 11:22
NT* 0 (%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

-

Today’s L/H

-
-

52 Wk L/H

-

L/U Price Band

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

  • VWAP
    -
    Series: NA
  • DELIVERY AVERAGES
    3-Day
    0%
    5-Day
    0%
    8-Day
    0%
    Deliverables
    0%
  • SMA
Medicamen Biotech is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      422.39
    • P/E
      34.96
    • Book Value (Rs)
      0
    • Dividend (%)
      0
    • Market Lot
      0
    • Industry P/E
      0
    • EPS (TTM)
      9.89
    • P/C
      29.55
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      0
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      0
      5-Day
      0
      8-Day
      0
      0

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      422.39
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      0
    • Market Lot
      0
    • Industry P/E
      0
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      0
      5-Day
      0
      8-Day
      0
      0

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
30 363.15 -
50 370.90 -
150 437.19 -
200 433.62 -
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

  • 0% BUY
  • 0% SELL
  • 100% HOLD
100%
of moneycontrol users recommend holding Medicamen Bio

What's your call on Medicamen Bio today?

Read 0 investor views

BUY SELL HOLD

Action in Medicamen Biotech Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Jun 2019 Mar 2019 Dec 2018 Sep 2018 Jun 2018
Net Sales 31.13 33.27 24.08 32.49 32.76
Other Income 0.04 0.62 0.07 1.81 1.16
PBDIT 5.02 4.28 4.38 4.14 4.21
Net Profit 3.28 2.84 2.40 3.56 3.22

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 11.70 11.70
Networth 86.63 74.61
Total Debt 11.63 14.39
Net Block 24.38 25.34
Investments 0.00 0.07
Total Assets 98.27 88.99

Historical Prices

On
Current Price %Gain / Loss
Open Price 437.70 328.05
-25.05
High Price 437.70 363.95
-16.85
Low Price 415.10 328.00
-20.98
Close Price 425.35 354.90
-16.56
Volume 4,505 10,272
128.01
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11661.90 75.50 0.65
SENSEX 39298.38 246.32 0.63
NIFTY BANK 29120.25 130.80 0.45
NIFTY IT 15410.10 128.20 0.84
S&P BSE Smallcap 13126.83 212.74 1.65
Index Price Change %Chg
Nasdaq (Oct 19) 8,089.54 -67.31 -0.83
DAX (Oct 18) 12,633.60 -21.35 -0.17
CAC (Oct 18) 5,636.25 -36.82 -0.65
FTSE (Oct 18) 7,150.57 -31.75 -0.44
SGX Nifty (Oct 19) 11,669.50 -12.00 -0.10

CORPORATE ACTION

Date Agenda
Aug 14, 2019 Quarterly Results & Others
May 30, 2019 Audited Results & Final Dividend
Apr 11, 2019 Preferential Issue of shares
Feb 11, 2019 Quarterly Results
Nov 13, 2018 Quarterly Results
Type Dividend% Ex-Dividend date
Final 10.00 Sep 17, 2019
Interim 10.00 Aug 08, 2017
Final 7.50 Sep 21, 2010
Final 0.00 Sep 11, 2002
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Medicamen Biotech
Old FV New FV Ex-Split
No Splits Information is available for Medicamen Biotech
Ratio Premium Ex-Bonus
No Rights Information is available for Medicamen Biotech
Date Agenda
Sep 25, 2019 -
May 06, 2019 -
Sep 26, 2018 -
Jan 12, 2018 -
Sep 13, 2017 -

Dividend Summary

For the year ending June 2019 Medicamen Biotech has declared an equity dividend of 10.00% amounting to Rs 1 per share. At the current share price of Rs NT* this results in a dividend yield of 0%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2019 June 2019 March 2019 December 2018
Promoters 44.77 44.77 44.53 44.53
Pledged 0 0 0 0
FII/FPI 0.47 0.47 0.49 0.49
Total DII 22.89 23.42 21.99 21.87
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 22.89 23.42 21.99 21.87
Others 31.87 31.34 33 33.11
Total 100 100 100.01 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Medicamen Bio 345.75 -2.58 555.95 306.00 422.39 122.60 12.21
Sun Pharma 401.40 0.00 616.50 350.40 96309.31 10,303.21 816.60
Divis Labs 1738.70 0.86 1768.80 1214.25 46157.02 4,879.66 1,332.65
Dr Reddys Labs 2723.80 -0.10 2965.20 2065.30 45254.78 10,625.50 1,277.30
Ranbaxy Labs 859.80 0.00 869.70 371.50 36598.55 6,864.94 -879.00

COMPANY OVERVIEW

Medicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products, such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum), and ointment. Its product offerings include Acarbrose Tablets 50 milligram, Acetazolamide Tablet 250 milligram BP, Amitriptyline Hcl Tablet 25 milligram, Amlodipine Besylate Tablet 10 milligram, and Sulfadoxine and Anti Malarial Kit. As of March 31, 2012, its production capacity under beta lactum included tablets (eight million per day), capsules (one million per day), oral liquid (4600 liters per day), and dry syrup (6000 kilogram per day). Its production capacity under non beta lactum included tablets (one million per day), capsules (one million per day), liquid (1300 liters per day), and dry syrup (50,000 bottles per day). The Company has two manufacturing at Bhiwadi and Haridwar.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Link Intime India Pvt. Ltd.

    • Address

      Naraina Industrial Area, Phase-II,Near Batra Banquet Hall

    • City

      New Delhi 110028

    • State

      Delhi

    • Tel. No.

      11-41410592, 41410593, 41410594

    • Fax No.

      11-41410591

    • Email

      delhi@linkintime.co.in

    • Internet

      http://www.linkintime.co.in

  • Management

    • Name

      Designation

    • Rahul Bishnoi

      Chairman

    • Ashwani Kumar Sharma

      Director

    • Harish Pande

      Director

    • Suresh Kumar Singh

      Director

    • Sanjay Bansal

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Medicamen Biotech Ltd.

Medicamen Bio is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 531146.

Related Searches